Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
REPR's Cash to Debt is ranked higher than
95% of the 316 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.05 vs. REPR: No Debt )
REPR' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: No Debt

Equity to Asset 0.86
REPR's Equity to Asset is ranked higher than
94% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.56 vs. REPR: 0.86 )
REPR' s 10-Year Equity to Asset Range
Min: -0.62   Max: 0.86
Current: 0.86

-0.62
0.86
Interest Coverage 1147.00
REPR's Interest Coverage is ranked higher than
77% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 38.06 vs. REPR: 1147.00 )
REPR' s 10-Year Interest Coverage Range
Min: 0.97   Max: 1147
Current: 1147

0.97
1147
F-Score: 6
Z-Score: 12.71
M-Score: -1.79
WACC vs ROIC
7.37%
23.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 10.20
REPR's Operating margin (%) is ranked higher than
77% of the 314 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.05 vs. REPR: 10.20 )
REPR' s 10-Year Operating margin (%) Range
Min: -23.01   Max: 24.28
Current: 10.2

-23.01
24.28
Net-margin (%) 6.70
REPR's Net-margin (%) is ranked higher than
77% of the 314 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.31 vs. REPR: 6.70 )
REPR' s 10-Year Net-margin (%) Range
Min: -25.71   Max: 29.98
Current: 6.7

-25.71
29.98
ROE (%) 13.10
REPR's ROE (%) is ranked higher than
84% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.20 vs. REPR: 13.10 )
REPR' s 10-Year ROE (%) Range
Min: -134.67   Max: 644.38
Current: 13.1

-134.67
644.38
ROA (%) 10.87
REPR's ROA (%) is ranked higher than
90% of the 318 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. REPR: 10.87 )
REPR' s 10-Year ROA (%) Range
Min: -36.99   Max: 57.04
Current: 10.87

-36.99
57.04
ROC (Joel Greenblatt) (%) 32.54
REPR's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.46 vs. REPR: 32.54 )
REPR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -85.27   Max: 95.7
Current: 32.54

-85.27
95.7
Revenue Growth (3Y)(%) 18.60
REPR's Revenue Growth (3Y)(%) is ranked higher than
96% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. REPR: 18.60 )
REPR' s 10-Year Revenue Growth (3Y)(%) Range
Min: -12.6   Max: 26
Current: 18.6

-12.6
26
» REPR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with REPR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.30
REPR's P/E(ttm) is ranked higher than
90% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 54.00 vs. REPR: 23.30 )
REPR' s 10-Year P/E(ttm) Range
Min: 2.45   Max: 40
Current: 23.3

2.45
40
PE(NRI) 21.00
REPR's PE(NRI) is ranked higher than
91% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.20 vs. REPR: 21.00 )
REPR' s 10-Year PE(NRI) Range
Min: 2.7   Max: 35
Current: 21

2.7
35
P/B 2.50
REPR's P/B is ranked higher than
77% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.19 vs. REPR: 2.50 )
REPR' s 10-Year P/B Range
Min: 1.04   Max: 28.8
Current: 2.5

1.04
28.8
P/S 1.40
REPR's P/S is ranked higher than
85% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.28 vs. REPR: 1.40 )
REPR' s 10-Year P/S Range
Min: 0.42   Max: 3.67
Current: 1.4

0.42
3.67
POCF 21.00
REPR's POCF is ranked higher than
80% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.08 vs. REPR: 21.00 )
REPR' s 10-Year POCF Range
Min: 3.73   Max: 28.8
Current: 21

3.73
28.8
EV-to-EBIT 11.52
REPR's EV-to-EBIT is ranked higher than
93% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 33.97 vs. REPR: 11.52 )
REPR' s 10-Year EV-to-EBIT Range
Min: -125.6   Max: 2673
Current: 11.52

-125.6
2673
PEG 3.09
REPR's PEG is ranked higher than
91% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. REPR: 3.09 )
REPR' s 10-Year PEG Range
Min: 0.33   Max: 5.26
Current: 3.09

0.33
5.26
Shiller P/E 9.70
REPR's Shiller P/E is ranked higher than
99% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. REPR: 9.70 )
REPR' s 10-Year Shiller P/E Range
Min: 3.9   Max: 40.4
Current: 9.7

3.9
40.4
Current Ratio 8.54
REPR's Current Ratio is ranked higher than
96% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.58 vs. REPR: 8.54 )
REPR' s 10-Year Current Ratio Range
Min: 0.79   Max: 9.6
Current: 8.54

0.79
9.6
Quick Ratio 6.76
REPR's Quick Ratio is ranked higher than
96% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. REPR: 6.76 )
REPR' s 10-Year Quick Ratio Range
Min: 0.28   Max: 7.47
Current: 6.76

0.28
7.47
Days Inventory 97.45
REPR's Days Inventory is ranked higher than
83% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 135.02 vs. REPR: 97.45 )
REPR' s 10-Year Days Inventory Range
Min: 81.94   Max: 230.05
Current: 97.45

81.94
230.05
Days Sales Outstanding 52.71
REPR's Days Sales Outstanding is ranked higher than
85% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 71.94 vs. REPR: 52.71 )
REPR' s 10-Year Days Sales Outstanding Range
Min: 29.25   Max: 73.22
Current: 52.71

29.25
73.22

Valuation & Return

vs
industry
vs
history
Price/Net Cash 10.50
REPR's Price/Net Cash is ranked higher than
94% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. REPR: 10.50 )
REPR' s 10-Year Price/Net Cash Range
Min: 7   Max: 24.9
Current: 10.5

7
24.9
Price/Net Current Asset Value 4.70
REPR's Price/Net Current Asset Value is ranked higher than
96% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. REPR: 4.70 )
REPR' s 10-Year Price/Net Current Asset Value Range
Min: 1.75   Max: 33
Current: 4.7

1.75
33
Price/Tangible Book 2.60
REPR's Price/Tangible Book is ranked higher than
83% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. REPR: 2.60 )
REPR' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 15
Current: 2.6

1.5
15
Price/DCF (Projected) 1.40
REPR's Price/DCF (Projected) is ranked higher than
88% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.17 vs. REPR: 1.40 )
REPR' s 10-Year Price/DCF (Projected) Range
Min: 0.68   Max: 8.4
Current: 1.4

0.68
8.4
Price/Median PS Value 1.10
REPR's Price/Median PS Value is ranked higher than
81% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.38 vs. REPR: 1.10 )
REPR' s 10-Year Price/Median PS Value Range
Min: 0.27   Max: 1.67
Current: 1.1

0.27
1.67
Price/Graham Number 1.60
REPR's Price/Graham Number is ranked higher than
91% of the 345 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. REPR: 1.60 )
REPR' s 10-Year Price/Graham Number Range
Min: 0.84   Max: 4.71
Current: 1.6

0.84
4.71
Earnings Yield (Greenblatt) 8.70
REPR's Earnings Yield (Greenblatt) is ranked higher than
93% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.60 vs. REPR: 8.70 )
REPR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 32.6
Current: 8.7

0.1
32.6
Forward Rate of Return (Yacktman) 6.90
REPR's Forward Rate of Return (Yacktman) is ranked higher than
72% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.96 vs. REPR: 6.90 )
REPR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.9   Max: 36.1
Current: 6.9

-2.9
36.1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Repro-Med Systems Inc was incorporated in the State of New York in March of 1980. The Company designs, manufactures and markets proprietary medical devices mainly for emergency medical applications and ambulatory infusion therapy. These products are regulated by the FDA. Its development and marketing focus are concentrated on the RES-Q-VAC(R) and the FREEDOM60(R) products. The FREEDOM60 uses an innovative 'engine' to create a constant pressure drive system. FREEDOM60(R) uses rate-controlled tubing with standard slide clamp and luer-lock connector on the patient end. Proprietary technology Employed in the FREEDOM60 uses constant pressure to administer drugs. FREEDOM60 avoids an important problem faced by electronic pumps currently on the market which Employ constant flow mechanisms that result in potentially dangerous, high pressures placed on indwelling catheters or under the skin. The Freedom60 Syringe Infusion Pump is designed for ambulatory medication infusions. The Company also designed and manufactured the Freedom60-FM, an enhanced version of the Freedom60 which contains an electronic flow monitor system that provides occlusion and end of infusion alarm. The Freedom60 use for Primary Immune Deficiency by injecting immune globulin under the skin as a subcutaneous administration continued to increase usage during the past year. This method has provided patients with improved quality of life with much fewer unpleasant side effects over the traditional intravenous route. The RES-Q-VAC(R) Emergency Airway Suction System is a lightweight, portable, hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC(R) pump to various proprietary sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The Company has introduced new, updated features including the FSP filter, new pediatric connectors, new graduated canister, new adult catheters, and new convenient carry pouch. It is also available with a flexible, portable LED white light source, which is attached to the top of the canister system and provides illumination for the medical professional during nighttime or low light conditions. The Company offers its products directly to large national accounts and emergency medical device distributors, as well as to regional distributors in the hospital respiratory care market.
» More Articles for REPR

Headlines

Articles On GuruFocus.com
comment on REPR Nov 13 2012 

More From Other Websites
REPRO MED SYSTEMS INC Financials May 19 2015
10-K for Repro-Med Systems, Inc. May 10 2015
REPRO MED SYSTEMS INC Files SEC form 10-K, Annual Report May 08 2015
REPRO MED SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 30 2015
REPRO MED SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 20 2015
Repro Med Systems, Inc. (REPR) Announces Appointment of New CFO Jan 20 2015
REPRO MED SYSTEMS INC Files SEC form 10-Q, Quarterly Report Jan 14 2015
REPRO MED SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other... Dec 23 2014
Repro Med Systems, Inc. (Repr) Announces Strong Results for Third Quarter Ended November 30, 2014 Dec 23 2014
REPRO MED SYSTEMS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial... Nov 05 2014
REPRO MED SYSTEMS INC Files SEC form 10-Q, Quarterly Report Oct 15 2014
REPRO MED SYSTEMS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 15 2014
RMS Medical Products Secures Additional Growth Capital Aug 11 2014
REPRO MED SYSTEMS INC Files SEC form 10-Q, Quarterly Report Jul 15 2014
REPRO MED SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... Jun 12 2014
RMS Announces Increased Sales, Organization and Personnel Changes Jun 12 2014
REPRO MED SYSTEMS INC Files SEC form 10-K, Annual Report May 29 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK